LaBranche, C. C., McGuire, A. T., Gray, M. D., Behrens, S., Chen, X., Zhou, T., … Montefiori, D. C. (2019). Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies. PLoS Pathog, 15(3), e1007646. https://doi.org/10.1371/journal.ppat.1007646

LaBranche, Celia C., Andrew T. McGuire, Matthew D. Gray, Shay Behrens, Xuejun Chen, Tongqing Zhou, Quentin J. Sattentau, et al. “Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.” PLoS Pathog 15, no. 3 (March 2019): e1007646. https://doi.org/10.1371/journal.ppat.1007646.

LaBranche CC, McGuire AT, Gray MD, Behrens S, Chen X, Zhou T, et al. Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies. PLoS Pathog. 2019 Mar;15(3):e1007646.

LaBranche, Celia C., et al. “Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.” PLoS Pathog, vol. 15, no. 3, Mar. 2019, p. e1007646. Pubmed, doi:10.1371/journal.ppat.1007646.

LaBranche CC, McGuire AT, Gray MD, Behrens S, Chen X, Zhou T, Sattentau QJ, Peacock J, Eaton A, Greene K, Gao H, Tang H, Perez LG, Saunders KO, Kwong PD, Mascola JR, Haynes BF, Stamatatos L, Montefiori DC. Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies. PLoS Pathog. 2019 Mar;15(3):e1007646.